IL13 and spindle cell hemangioma: As anticipated, SCH administration significantly reduced the OVA-induced increases in the levels of eotaxin (Figure 3(a)), IL-13 (Figure 3(b)), IL-5 (Figure 3(c)), and IL-4 (Figure 3(d)), and the high dosage of SCH exerted an obvious effect.